MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Depreciation andamortization$11,205K something is missing$9,956K Accounts receivable-$7,318K Equity-based compensation$3,264K Other current andnoncurrent assets and...-$522K Other, net$275K Provision for creditlosses$230K Deferred income taxes$135K Unrealized loss (gain) onforeign currency...-$54K Net cash fromoperating activities$8,934K Canceled cashflow$24,025K Net change in cashand cash...-$15,392K Canceled cashflow$8,934K Proceeds from issuance ofclass a common stock$120K Accounts payable andaccrued expenses-$15,367K Net income (loss)-$6,010K Inventories$2,648K Net cash fromfinancing activities-$23,144K Canceled cashflow$120K Effect of exchange ratechanges on cash-$608K Net cash frominvesting activities-$574K Payments on long-termdebt$22,000K Tax withholdings onequity-based compensation$1,044K Other, net-$220K Purchase of property andequipment$574K
Cash Flow

Bioventus Inc. (BVS)

Bioventus Inc. (BVS)

source: myfinsight.com